1,9-bis(8-methoxy-5H-pyrido[4,3-b]indol-5-yl)nonane

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 英文名称: 1,9-bis(8-methoxy-5H-pyrido[4,3-b]indol-5-yl)nonane
• 英文别名: 8-Methoxy-5-[9-(8-methoxypyrido[4,3-b]indol-5-yl)nonyl]pyrido[4,3-b]indole；8-methoxy-5-[9-(8-methoxypyrido[4,3-b]indol-5-yl)nonyl]pyrido[4,3-b]indole
• 化学式: C₃₃H₃₆N₄O₂
• 分子量: 520.674
• InChiKey: UHWJIWJJNDGXLH-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  7.2
• 重原子数：
  39
• 可旋转键数：
  12
• 环数：
  6.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  54.1
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  1,9-bis(8-methoxy-5H-pyrido[4,3-b]indol-5-yl)nonane 、 碘甲烷 以 丙酮 为溶剂， 反应 72.0h， 生成 1,9-bis((8-methoxy-2-methyl-5H-2λ4-pyrido[4,3-b]indol-5-yl)nonane diiodide)
  参考文献：
  名称：

  Evaluation of Homobivalent Carbolines as Designed Multiple Ligands for the Treatment of Neurodegenerative Disorders

  摘要：

  Neurodegenerative diseases represent a challenge for biomedical research due to their high prevalence and lack of mechanism-based treatments. Because of the complex pathology of neurodegenerative disorders, multifunctional drugs have been increasingly recognized as potential treatments. We identified homobivalent gamma-carbolinium salts as potent inihitors of both cholinesterases, N-methyl-D-aspartate receptors, and monoamine oxidases. Homobivalent gamma-carbolines displayed similar structure activity relationships on all tested targets and may present promising designed multiple ligands for the treatment of neurodegenerative disorders.

  DOI：

  10.1021/acs.jmedchem.5b00958
• 作为产物：
  描述：

  1,9-二溴壬烷 、 8-methoxy-5H-pyrido[4,3-b]indole 在 sodium hydroxide 作用下， 以 二甲基亚砜 为溶剂， 反应 1.0h， 生成 1,9-bis(8-methoxy-5H-pyrido[4,3-b]indol-5-yl)nonane
  参考文献：
  名称：

  Evaluation of Homobivalent Carbolines as Designed Multiple Ligands for the Treatment of Neurodegenerative Disorders

  摘要：

  Neurodegenerative diseases represent a challenge for biomedical research due to their high prevalence and lack of mechanism-based treatments. Because of the complex pathology of neurodegenerative disorders, multifunctional drugs have been increasingly recognized as potential treatments. We identified homobivalent gamma-carbolinium salts as potent inihitors of both cholinesterases, N-methyl-D-aspartate receptors, and monoamine oxidases. Homobivalent gamma-carbolines displayed similar structure activity relationships on all tested targets and may present promising designed multiple ligands for the treatment of neurodegenerative disorders.

  DOI：

  10.1021/acs.jmedchem.5b00958

文献信息

• Evaluation of Homobivalent Carbolines as Designed Multiple Ligands for the Treatment of Neurodegenerative Disorders
  作者：Robert Otto、Robert Penzis、Friedemann Gaube、Oliver Adolph、Karl J. Föhr、Paul Warncke、Dina Robaa、Dorothea Appenroth、Christian Fleck、Christoph Enzensperger、Jochen Lehmann、Thomas Winckler

  DOI：10.1021/acs.jmedchem.5b00958

  日期：2015.8.27

  Neurodegenerative diseases represent a challenge for biomedical research due to their high prevalence and lack of mechanism-based treatments. Because of the complex pathology of neurodegenerative disorders, multifunctional drugs have been increasingly recognized as potential treatments. We identified homobivalent gamma-carbolinium salts as potent inihitors of both cholinesterases, N-methyl-D-aspartate receptors, and monoamine oxidases. Homobivalent gamma-carbolines displayed similar structure activity relationships on all tested targets and may present promising designed multiple ligands for the treatment of neurodegenerative disorders.